1: Ampyra (fampridine SR) Lancet. 2009 Feb 28;373(9665):732-8. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR; Fampridine MS-F203 Investigators. Collaborators: Agius M, Arnason BG, Bethoux FA, Bever CT Jr, Bowen JD, Brown TR, Dietrich DW, Edwards K, Fr...